1. Home
  2. BNAI vs MEIP Comparison

BNAI vs MEIP Comparison

Compare BNAI & MEIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNAI
    SELLHOLDBUYas of 17 hours ago
  • MEIP
    SELLHOLDBUYas of 17 hours ago
  • Stock Information
  • Founded
  • BNAI 2018
  • MEIP 2000
  • Country
  • BNAI United States
  • MEIP United States
  • Employees
  • BNAI N/A
  • MEIP N/A
  • Industry
  • BNAI
  • MEIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • BNAI
  • MEIP Health Care
  • Exchange
  • BNAI NYSE
  • MEIP Nasdaq
  • Market Cap
  • BNAI 15.7M
  • MEIP 17.1M
  • IPO Year
  • BNAI N/A
  • MEIP 2003
  • Fundamental
  • Price
  • BNAI $0.31
  • MEIP $2.00
  • Analyst Decision
  • BNAI Strong Buy
  • MEIP Hold
  • Analyst Count
  • BNAI 1
  • MEIP 2
  • Target Price
  • BNAI $6.00
  • MEIP $7.00
  • AVG Volume (30 Days)
  • BNAI 379.5K
  • MEIP 8.6K
  • Earning Date
  • BNAI 05-25-2025
  • MEIP 05-08-2025
  • Dividend Yield
  • BNAI N/A
  • MEIP N/A
  • EPS Growth
  • BNAI N/A
  • MEIP N/A
  • EPS
  • BNAI N/A
  • MEIP N/A
  • Revenue
  • BNAI $99,790.00
  • MEIP N/A
  • Revenue This Year
  • BNAI $189.69
  • MEIP N/A
  • Revenue Next Year
  • BNAI $2,400.00
  • MEIP N/A
  • P/E Ratio
  • BNAI N/A
  • MEIP N/A
  • Revenue Growth
  • BNAI 125.10
  • MEIP 33.76
  • 52 Week Low
  • BNAI $0.30
  • MEIP $1.91
  • 52 Week High
  • BNAI $8.43
  • MEIP $4.10
  • Technical
  • Relative Strength Index (RSI)
  • BNAI 32.45
  • MEIP 21.00
  • Support Level
  • BNAI $0.36
  • MEIP $2.28
  • Resistance Level
  • BNAI $0.40
  • MEIP $2.35
  • Average True Range (ATR)
  • BNAI 0.03
  • MEIP 0.09
  • MACD
  • BNAI -0.00
  • MEIP -0.02
  • Stochastic Oscillator
  • BNAI 9.17
  • MEIP 17.43

Stock Price Comparison Chart: BNAI vs MEIP

BNAI
MEIP
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April01020304050607080BNAI VS MEIP

About BNAI BRAND ENGAGEMENT NETWORK INC

Brand Engagement Network Inc is an innovative AI platform provider, designed to interface with emerging technologies, including blockchain, the Internet of Things, and cloud computing, that drive digital transformation across various industries and provide businesses with an unparalleled competitive edge. BEN offers a suite of configured and customizable applications, including natural language processing, anomaly detection, encryption, recommendation engines, sentiment analysis, image recognition, personalization, and real-time decision-making.

About MEIP MEI Pharma Inc.

MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use